Fanfare abounds about quantum computing, but this is increasingly justified, especially as QC and AI integrate ever more closely. AI expert Prof Patrick Glauner of Germany’s Deggendorf Institute of Technology describes the current dynamic and forecasts its future course.

‘Hallucination,’ which refers to LLMs and other AIs presenting falsehoods as seemingly plausible facts, is a grave problem and one yet to be resolved. This becomes especially urgent when patients’ lives are at stake, although hope is at hand, writes ML developer Moein Shariatnia.

ML may augment clinical support for potentially deadly immune reactions due to sepsis. To devise, test, and implement clinical support tools in clinical practice is arduous, but common denominators from successful use may apply to other severe conditions. Medical and analytics researcher Matthew Marcetich reports.

Healthtech is now more than a fad. Apps and wearables are just the start: Healthtech can potentially improve health for a huge range of people, but equal access is key, says Marketing and Commercialization Prof Marzena Nieroda of the UCL Global Business School for Health, London.

Single-cell RNA sequencing is a mighty weapon in cancer research that maps cell types and states, both individually and in clusters. ML then pares down the ensuing reams of data for ease of analysis. ML genetic and healthcare data specialist Dr Sara Moein explains their workings.